weight loss medication retatrutide drug use requires strict supervision, doctor says Retatrutide for weight loss: Study

Discontinuation Rates TRIUMPH-1's 11.3% rate is an improvement over TRIUMPH-4's 18.2%, suggesting the general obesity population tolerates retatrutide meaningfully better than the older, more comorbid OA population

The 2024 label update slightly extended this for some dose strengths, so check your specific pens instructions

What Self-Pay Actually Costs in 2026 With roughly two-thirds of employers not covering GLP-1s for weight loss, self-pay remains the reality for most patients

Participants in the retatrutide 4/8/12 mg group most frequently reported improved mobility or ability to perform physical activity (n = 19

Long-term, prospective studies are still needed, Hardaway said

Triple-check them